CHRISTIE WALTERS: Open Payments
NPI 1952593378 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 40 payments from 14 companies in 2025. Trend: 2023 $1,397 · 2024 $609 · 2025 $806
Food & beverage: $716Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 12 | $270 |
| Sage Therapeutics, LLC | 8 | $139 |
| Hologic Sales and Service, LLC | 3 | $71 |
| Lilly USA, LLC | 3 | $54 |
| Sumitomo Pharma America, Inc. | 1 | $52 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| Novo Nordisk Inc | 2 | $36 |
| Exeltis, USA Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $20 |
Products named: Veozah, ZURZUVAE, ZEPBOUND, GEMTESA, MYOSURE TISSUE REMOVAL DEVICE, Qelbree, ACCRUFER, Wegovy.
Industry payments across LA — which companies pay providers there.
